Sponsor:
Mayo Clinic
Code:
NCT07213466
Conditions
Bipolar I Disorder
Bipolar II Disorder
Schizo Affective Disorder
Obesity
Weight Loss
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
Group Therapy Program
semaglutide
Phentermine-Topiramate
naltrexone and bupropion (combination)
Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-25. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-03-11.